Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, interim trial results suggest

After criticism last year for an early rollout, Russia’s Sputnik V vaccine is 91.6% effective against symptomatic Covid-19 and 100% effective against severe and moderate disease, according to an interim analysis of the vaccine’s Phase 3 trial results.